Can financial incentives and other nudges increase COVID-19 vaccinations among the vaccine hesitant? A randomized trial

Vaccine. 2022 Oct 12;40(43):6235-6242. doi: 10.1016/j.vaccine.2022.08.060. Epub 2022 Aug 30.

Abstract

Despite rapid initial uptake, COVID-19 vaccinations in the United States stalled within a few months of widespread rollout in 2021. In response, many state and local governments, employers and health systems used public health messaging, financial incentives and creative scheduling tools to increase vaccine uptake. Although these approaches drew on evidence from influenza and other vaccination efforts, they were largely untested in the context of SARS-CoV-2. In mid-2021, months after vaccines were widely available, we evaluated vaccination intentions and vaccine uptake using a randomized control trial. To do this, we recruited unvaccinated members of a Medicaid managed care plan in California (n = 2,701) and randomly assigned them to different public health messages, $10 or $50 financial incentives for vaccination, a simple vaccination appointment scheduler, or control. While messages increased vaccination intentions, none of the interventions increased vaccination rates. Estimates for financial incentives rule out even relatively small increases in vaccination rates. Small financial incentives and other behavioral nudges do not meaningfully increase COVID-19 vaccination rates amongst the vaccine hesitant.

Keywords: COVID-19 vaccination; Financial incentives; Public health messages; Vaccine hesitancy.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Humans
  • Influenza Vaccines*
  • Motivation
  • SARS-CoV-2
  • United States
  • Vaccination

Substances

  • COVID-19 Vaccines
  • Influenza Vaccines